Myf5: A Potential Drug Target and Biomarker for Cancer (G4617)

Target Name: MYF5

NCBI ID: G4617

MYF5

Myf5: A Potential Drug Target and Biomarker for Cancer

Myf5 (bHLHc2) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 12 and encodes a protein known as Myf5.

Myf5 is a transcription factor that plays a role in the regulation of gene expression. It is expressed in a variety of tissues, including the brain, heart, and gastrointestinal tract, and has been shown to be involved in the development and maintenance of tissues.

One of the most promising aspects of Myf5 is its potential as a drug target.MYF5 has been shown to be highly expressed in a variety of cancer types, including breast, ovarian, and colorectal cancer. It has also been shown to play a role in the regulation of cell proliferation and survival, which are key factors in the development and progression of many diseases.

In addition to its potential as a drug target, Myf5 has also been identified as a potential biomarker for cancer. Its expression has been shown to be associated with the development and progression of various diseases, including cancer. This suggests that Myf5 may be a useful indicator of disease status in cancer patients.

Another potential use for Myf5 is its role in the regulation of stem cell proliferation.MYF5 has been shown to play a role in the regulation of stem cell proliferation and has been shown to be involved in the development of cancer stem cells. This suggests that Myf5 may be a potential target for therapies aimed at inhibiting cancer stem cell proliferation.

In conclusion, Myf5 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role and potential in the development and treatment of cancer and other diseases.

Protein Name: Myogenic Factor 5

Functions: Transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation (PubMed:29887215). Together with MYOG and MYOD1, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Probable sequence specific DNA-binding protein

The "MYF5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYF5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets